Intelligence Platform
Patents
Browse 1,164 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9415105
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to
granted patentUS 9409994
High-affinity monoclonal antibodies to glypican-3 and use thereof
granted patentUS 9409992
Mesothelin domain-specific monoclonal antibodies and use thereof
granted patentUS 9409956
Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof
granted patentUS 9402889
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted patentUS 9402820
Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for th
granted patentUS 9399672
Hepatitis C virus neutralizing antibody
granted patentUS 9394364
Human monoclonal antibodies specific for glypican-3 and use thereof
granted patentUS 9394358
Gene signature for predicting prognosis of patients with solid tumors
granted patentUS 9394352
Immunogenic POTE peptides and methods of use
granted patentUS 9394316
Inhibitors of the plasmodial surface anion channel as antimalarials
granted patentUS 9388222
Modified Pseudomonas exotoxin A
granted patentUS 9382311
HIV-1 broadly neutralizing antibodies
granted patentUS 9364557
Fold-back diabody diphtheria toxin immunotoxin and methods of use
granted patentUS 9364448
Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation
granted patentUS 9358285
Granulysin in immunotherapy
granted patentUS 9359418
Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use
granted patentUS 9359447
Anti-mesothelin chimeric antigen receptors
granted patentUS 9353353
Virus-like particles (VLPs) prepared from chikungunya virus structural proteins
granted patentUS 9346859
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
granted patentUS 9345748
Anti-SSX-2 T cell receptors and related materials and methods of use
granted patentUS 9341619
Hyposialylation disorders
granted patentUS 9333251
Vaccine for protection against Shigella sonnei disease
granted patentUS 9326950
Self-assembling nanoparticles composed of transmembrane peptides and their application for
granted